Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Interview with Aram Mangasarian, CEO of NOXXON
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Discussing the company's latest data and strategy
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Exploring Cesium and Cobalt Opportunities in Kalgoorlie: Pioneer Resources' Strategic Initiatives
00:10:00
France's Business Environment, Market Outlook, and Growth Strategy
00:10:00
focusing on investments in the e-commerce retail|Dan Rosen,Founder and General Partner,Commerce Ventures
00:10:00
Built and scaled several startups and invested in over 65 companies|John Francis,General Partner,Stout Street Capital
00:10:00
Your financial well-being is our first priority|Nancy Mullally CEO, CFO, Chairman of the Board, Alamo capital
00:00:00
Reggie Groves, CEO, REVA Medical Inc
00:10:00
Investing in Greece: From Contrarian Bet to Mainstream Opportunity | Mr. Stelios Theodosiou, Managing Director, H.I.G. Capital.
00:10:00
Labor Market Imbalances: A Challenge for the Federal Reserve
00:10:00
Exploring the Surge of Multi-Manager Platforms and Their Impact on Diversification and Risk Management with Insights from Curtis Arledge and Joe Lacovara of Mariner Investment Group
00:10:00
Radio frequencies are being used in a trial project in Alberta to heat the oil sands and reduce pollution | GEOFF CLARK, Chief Executive Officer, Acceleware LtdAXE:CVE
00:10:00
The Impact of COVID-19 on Family-Owned Businesses: Insights from Byron Trott | Byron Trott, Co-CEO , BDT & MSD Partners .
00:10:00
In-Depth Insights with Paul Singer: A Conversation on Principled Entrepreneurship at the Napa Institute 2020 Conference with Princeton's Robert P. George